IL17A and neoplasm: Meta-analysis showed that high level of IL-17A within tumor was significantly associated with decreased DFS in solid tumors (HR = 1.70, 95% CI 1.17 to 2.46, P = 0.005) (Supplementary Figure 2); while significant heterogeneity was observed (I2= 78.9%; P = 0.000).